DeepMed Research

HTL-0030310

Generic Name: HTL-0030310

Advanced Drug Monograph

Access comprehensive pharmacological analysis, clinical applications, and therapeutic considerations.

Clinical Trials

A Study in Healthy Subjects to Assess the Safety, Tolerability, PK and PD of HTL0030310

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: HTL0030310
Drug: Pasireotide
Drug: Placebo

First Posted Date: 2019-02-20

Last Posted Date: 2025-02-19

Lead Sponsor: Nxera Pharma UK Limited

Target Recruit Count: 42

Registration Number: NCT03847207

Locations: 🇬🇧
Quotient Sciences, Nottingham, United Kingdom

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy